Atypical Antipsychotics

DRUG2 trials

Sponsors

Pontifical Catholic University of Argentina, Janssen Research & Development, LLC

Conditions

Bipolar Depressive DisorderMajor Depressive DisorderParkinson's Disease With HallucinationsSchizophreniaStroke

Unknown Phase

Clinical Registry of Patients Under Treatment With Atypical Antipsychotics

CompletedNCT02409823

Pontifical Catholic University of ArgentinaBipolar Depressive Disorder, Major Depressive Disorder, Parkinson's Disease With Hallucinations +1

Start: 2015-02-28End: 2015-08-31Updated: 2015-10-20

A Study to Assess Stroke Risk Among Users of Typical Versus Atypical Antipsychotics Stratified by Broad Age Group

CompletedNCT04002700

Janssen Research & Development, LLCStroke

Start: 2019-05-06End: 2019-05-31Updated: 2025-06-25

Related Papers

Movement Disorders After Exposure to Antipsychotic Drugs in Patients With Depressive Disorders

Clinical Neuropharmacology2018-09-012 citations

Factors Related to Early Clinical Effects of Quetiapine Extended-Release: A Multinational, Prospective, Observational Study.

2016-06-012 citations